Etoposide compared with the combination of vincristine, doxorubicin, and cyclophosphamide in the treatment of small cell lung cancer.

One hundred and three patients with small cell lung carcinoma were stratified according to stage of disease (47 limited disease, 56 extensive disease) and then randomised to receive etoposide 300 mg/m2 alone for two days or a combination (VAC) of vincristine 1 mg/m2, doxorubicin (Adriamycin) 50 mg/m...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: McIllmurray, M B, Bibby, R J, Taylor, B E, Ormerod, L P, Edge, J R, Wolstenholme, R J, Willey, R F, O'Reilly, J F, Horsfield, N, Johnson, C E
Format: Artigo
Idioma:Inglês
Publicat: 1989
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC461757/
https://ncbi.nlm.nih.gov/pubmed/2539655
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars